首页    期刊浏览 2024年11月06日 星期三
登录注册

文章基本信息

  • 标题:National Trends and Disparities in the Incidence of Hepatocellular Carcinoma, 1998–2003
  • 本地全文:下载
  • 作者:Faruque Ahmed, PhD ; Joseph F. Perz, DrPH ; Sandy Kwong, MPH
  • 期刊名称:Preventing Chronic Disease
  • 印刷版ISSN:1545-1151
  • 出版年度:2008
  • 卷号:05
  • 期号:03
  • 出版社:Centers for Disease Control and Prevention
  • 摘要:

    Introduction
    Previous studies indicate that the incidence of hepatocellular carcinoma in the United States is increasing. These reports, however, have contained limited information on population groups other than whites and blacks.

    Methods
    We assessed recent incidence rates and trends for hepatocellular carcinoma by using newly available national data from cancer registries participating in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program. Data from registries in 38 states and the District of Columbia met our criteria; these data covered 83% of the U.S. population. We computed age-adjusted incidence rates and annual percentages of change from 1998 through 2003.

    Results
    The registries that we used reported 48,048 cases of hepatocellular carcinoma (3.4 cases per 100,000 population per year) for the study period. Whites accounted for three-fourths of cases. The incidence rate for blacks was 1.7 times higher than that for whites, and the rate for Asians/Pacific Islanders was 4 times higher than that for whites. Hispanics had 2.5 times the risk of non-Hispanics. Among Asian/Pacific Islander subgroups, rates were highest for people of Vietnamese and Korean origin. For all races/ethnicities combined, the annual percentages of change were 4.8% for males and 4.3% for females (P < .05). The annual percentage of change was highest for people aged 45–59 years (9.0%, P < .05). The annual percentage of change for Asians/Pacific Islanders was statistically unchanged.

    Conclusion
    We document rising incidence rates of hepatocellular carcinoma in the United States during a time when the overall incidence of cancer has stabilized. Efforts to collect representative etiologic data on new hepatocellular carcinoma cases are needed to enable better characterization of trends and to guide the planning and evaluation of prevention programs.

国家哲学社会科学文献中心版权所有